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Abstract
Background: The hyperdense artery sign (HAS) on CT brain scan is an assumed radiological marker of acute intra-arterial
thrombotic occlusion. However, the relationship between HAS between time of stroke onset has not been adequately
investigated, leading to uncertainty regarding its validity as a marker of acute ischaemia. We attempted to determine if
the presence of the hyperdense artery sign is associated with time from stroke onset.
Methods: Retrospective cross-sectional study conducted in a tertiary referral centre. Consecutive patients with acute
ischaemic stroke and confirmed middle cerebral arterial occlusion on initial CT angiogram from 2007–2011 were included.
Visual estimation and manual measurement of Hounsfield units of affected and corresponding non-affected artery on
non-contrast CT was completed and mean density was calculated from four separate readings. Primary outome measures
were Time from stroke onset and HAS on both visual estimation and the ratio of mean value in Hounsfield Units (HU) of
affected to non-affected artery.
Results: One hundred and fifty-four subjects with confirmed arterial occlusion on CT Angiogram were included in the
study. There were no significant differences in age distribution or vascular risk factor presence between subjects with or
without HAS. Subjects with HAS were less likely to be male (50.9 % vs 70.8 %, p = 0.02).) HAS was found in 106 (68.8 %) of
all subjects. Median NIHSS score at presentation was significantly higher in the HAS group (17 vs 12, p= 0.02). No statistically
significant association between HAS and stroke onset time or density ratio between affected and non-affected artery was
detected overall within either the first 24-h or on subgroup analysis of those in the first 4.5-h. A small subgroup of three
patients with stroke onset greater than 24-h all had absent HAS.
Conclusions: No evidence of a correlation between time of stroke onset and presence of a HAS within the first 24-h
post acute ischaemic stroke was identified. The HAS was associated with a higher NIHSS score at presentation.
Keywords: Ischaemic Stroke, Hyperdense artery sign, Susceptibility vessel sign, Stroke imaging, Neuroimaging, Acute
stroke
Background
Despite the development of newer imaging modalities,
non-contrast computed tomography (NCCT), given its
wide accessibility, remains the principal imaging technique
in suspected acute stroke. The hyperdense artery sign
(HAS) was first described in 1983 as a radiological marker
of intra-arterial thrombotic occlusion and, although not
definitively unproven, was possibly an early sign of acute
ischaemic stroke [7]. Although HAS is widely described in
the middle cerebral artery, termed Hyperdense Middle
Cerebral Artery Sign (HMCAS), it is also reported in
internal carotid artery, posterior cerebral artery, basilar
artery and to a lesser extent, anterior cerebral artery [2, 5,
6, 8–10, 15, 20].
HAS is defined as region of hyperdensity in compari-
son to the artery on the contralateral side, as seen on
NCCT (Figure 1). This has been reported to be present
on NCCT in 75 % of acute ischaemic stroke within the
first 90 min of symptom onset [14, 24, 25]. The overall
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prevalence of HMCAS in acute ischaemic stroke varies
in published studies between 5-75 % with the largest sys-
tematic review indicating a prevalence of around 25 %
[28]. The vast majority of studies to date define a hyper-
dense artery as one that is denser than its contralateral
counterpart when assessed by one or more neuroradiol-
ogists [3, 10, 15, 16, 20, 28].
Recent evidence suggests that clot density on NCCT re-
flects the composition of the clot [17]. Normally flowing
blood column is characterized by a Hounsfield value of
approximately 40 units, where an acute clot within a vas-
cular structure averages closer to 61–80 units [17, 19]. As
the acute thrombus progresses, its composition changes
from RBC-rich ‘red thrombus’ to a predominately fibrin-
based ‘white thrombus’. It has been postulated that the
extrusion of serum in an acute thrombus, and subsequent
increased haemoglobin concentration, is the cause of the
increase in density on NCCT [19]. Kirchhof et al. showed
that white thrombi had a CT attenuation of 24 +/− 8 HU
compared to red thrombi at 76 +/− 9 HU, with a linear
relationship between haematocrit level and CT attenu-
ation [13]. Presumably it also reflects the acuity of the
thrombus, although further research is required to deter-
mine the specific relationship between time from symp-
tom onset and the presence of the HAS. A non-significant
relationship has been noted on previous studies, although
this has not been examined as a primary outcome [15, 20].
Despite this, prior studies involving intra-arterial thromb-
olysis have used the HAS and it’s subsequent disappear-
ance as both a selection criteria and outcome measure to
define successful recanalization in the first 24-h.
The potential benefits of further imaging guidance to
identify onset time is pertinent in the time critical setting
of potential thrombolysis within the first 4.5-h following
stroke. Although advanced imaging systems examining
penumbra and perfusion show promise they are still not
available in all centres. In this study, we aimed to establish
the relationship between stroke onset time and the HAS.
Methods
Participants
All patients presenting with an ischaemic stroke between
2007–2011 to the Royal Melbourne Hospital stroke care
unit who had both NCCT (4.5 mm slices) and CT-
Angiogram (CTA) on admission were retrospectively
identified from the stroke database. Patients imaging
was reviewed to identify those who had confirmed vessel
occlusion on CTA that corresponded clinically with
presenting symptoms. Those who either had haemor-
rhagic strokes or no confirmed arterial occlusion on
CTA were excluded from the study as were those with
strokes not affecting the Middle Cerebral Artery (MCA).
Demographic and stroke risk factors including hyperten-
sion, diabetes, age, smoking history, history of atrial
fibrillation, hypercholesterolaemia were extracted from
the stroke database. Ethics approval was granted via the
human research ethics committee prior to commencement.
Procedures
All NCCTs were reviewed by a blinded assessor (JH) to
identify the Hyperdense Middle Cerebral Artery
(HMCA) defined as an MCA denser than its contralat-
eral counterpart including the ‘dot’ sign of the MCA in
the sylvian fissure. All hyperdense signs carried the add-
itional criteria of disappearance of the increased density
on bone window settings. Four random 1 mm2 spot
measurements in Hounsfield Units (HU) were taken
from the highest density area on visual estimation of the
affected artery and the mean of these values used, with
similar measurements taken from the corresponding
non-affected artery on the contralateral side.
Following identification of the HAS, the corresponding
CTA was then reviewed. Cases were excluded where a
corresponding arterial occlusion was not identified on
CTA at the site of the HAS. A randomized subset of
two-third of all NCCTs and corresponding CTAs were
reviewed independently by a second blinded neuroradi-
ologist (one of BY, PJM or RJD). The interobserver
agreement for the HAS and occlusion was assessed
using Cohen’s kappa statistics.
Time of stroke onset data was collected and stored in
the stroke registry. Where a wake-up stroke occurred,
time of stroke onset was measured as midnight.
Data analysis
Statistical analyses were performed using Stata IC v12
software. Data are presented as means and standard devia-
tions or medians and interquartile range for continuous
variables and as counts and percentages for categorical
variables. Univariate comparisons of various factors of
interest between HAS and non-HAS groups were made
using Wicoxon-Mann–Whitney ranksum test or Fisher’s
exact test depending on the nature of the underlying dis-
tribution. The differences in time from onset of stroke
symptoms in patients with and without HAS were
assessed using Wicoxon-Mann–Whitney ranksum test,
while the magnitude of association between time from
onset of stroke symptoms and the ratio of artery density
between affected/non-affected arteries was assessed using
Spearman correlation coefficient. For all statistical
analyses, the significance level was set at a p < 0.05.
Results
A total of 154 subjects with acute ischaemic stroke and
corresponding MCA arterial occlusion on CTA were
included in the in the study. Of these, 106 (68.8 %) had
a HAS and 7 (4.5 %) were wake-up strokes. There were
no significant differences in age distribution or vascular
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risk factor presence between subjects with or without
HAS. There was a significantly higher proportion of
males in the group with an absent HAS (70.8 % vs
50.9 %, p = 0.02). Median admission NIHSS scores in the
HAS group (17 points, interquartile range 10 – 21) were
significantly greater than in the non-HAS group (12
points, interquartile range 7–18, p = 0.02). Mean dis-
charge Modified Rankin Score was significantly higher
in the HAS group (3.9 vs 3.2, p = 0.01). The baseline and
summary characteristics of the subjects are listed in
Table 1.
Interrater agreement on review of 102 scans (66 % of
total) by a second neuroradiologist of a randomised
subset of subjects for visual estimation of the HAS was
moderate, with a kappa value 0.60.
Within the first 24-h, the median time from onset of
stroke symptoms in patients with HAS was 134 min
(interquartile range 89–263 min) and without HAS
126 min (interquartile range 85 – 345 min), resulting in
the absence of the evidence of statistically significant as-
sociation between the HAS on visual estimation and
time from stroke within the first 24-h (p = 0.70). Ratio of
artery density between affected/non-affected arteries
similarly was not significantly associated with time from
stroke onset within the first 24-h (Spearman’s Rho = −0.8;
p = 0.42).
On subgroup analysis comparing 118 subjects present-
ing within the first 4.5-h post stroke onset with 36 sub-
jects presenting 4.5-24 h post onset, there was no
significant association between presence or absence of
the HAS on visual estimation (Fisher’s exact p = 0.83).
Ratio of artery density between affected/non-affected
arteries was not significantly associated with presenting
prior to 4.5-h vs 4.5-24 h (Wilcoxon-Mann–Whitney
p = 0.42).
Figure 2 displays a scatterplot of the ratio to time from
stroke onset. An additional three subjects were excluded
due to presenting greater than 24-h post stroke onset.
All of these subjects had an absent HAS. There were no
significant differences in age distribution, sex ratio or
presence of vascular risk factors between the groups less
than/greater than 24-h post stroke onset.
Discussion
Accurate determination of stroke onset time has gained
increasing importance with the advent of time-dependent
thrombolysis. The benefits on thrombolysis in the first
4.5 h has increased the necessity of objective means to
assist in determining stroke onset, especially in patients
who are unable to communicate or remember the onset
of stroke symptoms (such as wake-up strokes). Newer im-
aging techniques such as diffusion-weighted MRI and CT-
perfusion have yet to show clear guidance as to specific
stroke onset time, and are available only in larger centres.
Our study further attempted to define the relationship
between the HAS and stroke onset time. Previous stud-
ies have consistently found the HAS to be an early sign
of ischaemia [6, 8, 10, 15, 20]. The association between
time of stroke onset, imaging time and presence of HAS,
however has not been studied as a primary outcome.
The HMCAS has consistently shown to be associated
with earlier presentation [22], poor clinical outcome and
Table 1 Summary statistics for patients with and without hyperdense artery sign
Characteristic Patients with HAS Patients without HAS P Value
Number, n(%) 106 (68.8) 48 (31.2)
Age, mean (SD), y 69.7 68.4 0.62
Male, n (%) 54 (50.9) 34 (70.8) 0.02
Vascular Risk Factors, n (%)
Hypertension 62 (58.5) 29 (60.4) 0.82
Diabetes Mellitus 23 (21.7) 12 (25.0) 0.65
Cholesterol, mean 4.49 mmol/L 4.60 mmol/L 0.72
Atrial Fibrillation 40 (37.7) 16 (33.3) 0.6
Smoking 24 (22.6) 11 (22.9) 0.97
Ischaemic Heart Disease 21 (19.8) 16 (33.3) 0.07
Previous stroke 12 (11.3) 5 (10.4) 0.87
NIHSS Score admission, median (range) 17 (0–39) 12 (0–27) 0.02
Stroke onset to NCCT, median (range) 134 (52–1092) 126 (34–997) 0.76
Ratio affected:non-affected artery, median (range) 1.44 (1.09–2.00) 1.02 (0.84-1.47) 0.001
Mean artery density affected artery (HU) 59.0 42.9
Death, n (%) 11 (10.4) 2 (4.2) 0.08
MRS at discharge, mean (range) 3.9 (0–6) 3.2 (0–6) 0.01
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prognosis [11, 18, 24, 27], severe neurological deficits
and larger stroke territory [18, 24, 27]. Initial NIHSS/
MRS scores and outcome at three-months are signifi-
cantly worse in patients presenting with HMCAS [8, 11,
16, 18, 24, 27, 28]. Our study similarly displayed a
significantly higher NIHSS score at admission with a
present HAS as well as poorer clinical outcome as
evidenced by higher discharge Modified Rankin Score.
There was a trend towards greater mortality with a HAS
in our study however this was not statistically
significant.
Although clot density on NCCT has been reported to
decrease in a linear fashion in comparison to time, this
has not been specifically studied in relation to time from
symptom onset as a primary outcome [4]. In a large
study of the SITS register by Kharitonova et al., repre-
senting 1905 subjects with a HMCAS at presentation,
48 % had a disappearing HMCAS at 22–36 h after
thrombolysis [12]. Those with a disappearing HMCAS
on follow-up scan were significantly younger, less likely
to have initial CT signs and had milder strokes as measured
by initial NIHSS score. Early improvement in NIHSS was a
significant predictor for disappearing HMCAS [12]. It is
uncertain from the literature as to whether a disappearing
HMCAS represents recanalization vs change in clot com-
position and likewise a persisting HMCAS may not always
equate with continued occlusion [12, 22, 26]. Our finding
of a higher NIHSS with the HAS, consistent with other
studies, may be associated with larger or more prolonged
arterial occlusion. The natural history of the HMCAS and
rate of disappearance has not been specifically examined to
date.
We found that a present HAS (by visual estimation)
may be associated with time only on a small subset of
patients 24-h post stroke onset. Our findings also show
that the HAS is not associated with earlier presentation,
Fig. 2 Ratio of affected to non-affect mean artery density by time from stroke onset with vertical line displaying 4.5-h mark
Fig. 1 R MCA Hyperdense artery sign
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although notably further studies examining subjects pre-
senting greater than 24-h would be beneficial. Previous
studies have reported a prevalence of hyperdense MCA
sign at 75 % in the first 3-h and in 15 % from hours 12–24.
Studies with hyperdense PCA and basilar signs have
yielded similar results [15].
Similarly, there was no association between ratio of af-
fected: non-affected mean artery density and time from
stroke onset within the first 24-h. Prior studies have
reported significantly reduced false positive rates when
using measurement of absolute attenuation of affected
and normal vessels, using a ratio of > 1.2 [14]. Our finding
of a significantly reduced ratio in the subgroup of patients
greater 24-h post stroke, although modest, may assist as a
guide to determining stroke onset.
We also analysed a subgroup of patients presenting
within the first 4.5-h post stroke onset, given accurate de-
termination of stroke onset time in this period is clinically
applicable to eligibility for thrombolysis. This subgroup
did not display a statistically significant association with
either presence of the HAS or arterial density ratio in
comparison to those presenting 4.5-24 h post stroke
onset.
More recently the HAS has been used as an element of
functional outcome predictor scores (the DRAGON
criteria) and a prognostic marker for thrombolysis [1, 23].
The HAS is a common inclusion in the development of
functional outcome predictors scores for patients who
receive thrombolysis [1, 23]. The lack of time-dependency
of the HAS that was shown in our study should be consid-
ered in the use of these measures.
There were a number of limitations to our study. The
vast majority of scans in our study were taken on
4.5 mm thick slice NCCT, with thin-slice NCCT only
recently initiated on a regular basis in our institution.
Recent evidence suggests that thin-slice NCCT allows
more reliable and sensitive detection of arterial occlu-
sion and has significantly higher inter-rater reliability
[21]. Further studies using thin-slice NCCT may yield
further information regarding the usefulness of HAS in
predicting time from stroke onset.
Conclusion
We showed that the likelihood of HAS in acute ischae-
mic stroke is not associated with time from onset of
stroke within the first 4.5 or 24-h. Ratio of absolute
artery density between affected and non-affected artery
similarly is not associated with time from stroke onset.
The HAS was associated with a higher NIHSS score at
presentation.
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